Drug Profile
Clostridium difficile vaccine - Aviex Technologies
Alternative Names: AVX-101 - Aviex Technologies; Prophylactic clostridium difficile vaccine - Aviex TechnologiesLatest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator Aviex Technologies
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Clostridium difficile infections
Most Recent Events
- 13 Sep 2023 Discontinued - Preclinical for Clostridium difficile infections (Prevention) in USA (PO)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Clostridium-difficile-infections(Prevention) in USA (PO)
- 02 Aug 2016 Preclinical trials in Clostridium difficile infections (Prevention) in USA (PO)